UBS lowered the firm’s price target on Altice USA to $4 from $6 and keeps a Buy rating on the shares. While Altice isn’t immune to market pressures, it is seeing progress and the firm expects improvement in 2024 as the company works back to growth, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ATUS:
